Lexaria Bioscience Corp. — Director's Dealing 2021

Sep 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lexaria Bioscience Corp. (LEXX)
CIK: 0001348362
Period of Report: 2021-09-01

Reporting Person: BUNKA CHRISTOPHER (Director, CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-09-01	Stock Options	$6.23	A	15000	Acquired	2026-09-01	Common Shares (15000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
common shares	215912	Indirect
common shares	273543	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrants	$10.5	2025-05-06	Common Shares (6667)	6667	Indirect
Stock Options	$5.83	2026-04-26	Common Shares (26000)	32667	Direct
Stock Options	$7.08	2026-06-08	Common Shares (23334)	56001	Direct